STING, SUMO In Spotlight As Takeda Showcases Oncology Progress

 
• By Ian Haydock
  
Treatment for malignant cancer cells in a human body caused by environmental carcinogens and genetics as a target aiming at the cancerous cell as an immunotherapy therapy as a 3D illustration.
Cancer Firmly In Takeda's Sights As Pipeline Progresses • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D